4CASTING the Future: Innovations in Triple Negative Breast Cancer
Triple negative breast cancer remains one of the most challenging types to treat because it lacks the common treatment targets, grows and spreads aggressively, is highly diverse and currently has limited effective therapies – but new research is changing the story.
Associate Professor Rachel Dear takes us inside the 4CAST trial showing how science moves from bench to…